Sickle Cell Disease and Cannabis
Jay R. Cavanaugh, Ph.D.
Some 70,000
Americans suffer from Sickle Cell Disease. Sickle Cell is a genetic blood
disorder that primarily affects African Americans, Latinos, and those of
Mediterranean origin. One African American in 650 will be born with the
disease. Sickle Cell is about half as prevalent in Latino and Mediterranean
origin. Even Caucasians can be borne with Sickle Cell disease.
Normal red
blood cells are made of two types of hemoglobin and have a round shape that
allows the blood cells to move through capillaries. A mutation of one type of
hemoglobin can produce malformed hemoglobin that causes the red blood cells to
adopt a sickle shape which causes the red blood cells to clog capillaries.
Sickle cell
disease is a recessive genetic trait. Carrying just one sickle gene actually
confers a greater ability to fight malarial infections while carrying two
sickle cell genes results in defective red blood cells responsible for the
symptoms of the disease. Routinely genetic screening (a blood test and/or DNA)
should be done if any relatives have the disease. If one of the parents is a
carrier and the other not then there is no chance that offspring will have the
disease but they will have a 50% of being a carrier. If both parents are carriers
the chances are ¼ that the child will have Sickle Cell and ¾ chance of being a
carrier of the mutant gene.
The only
“cure” for Sickle Cell Disease is a painful bone marrow transplant assuming an
appropriately matched donor can be found. Those with the disease usually have
lives shortened by the bodies reduced ability to fight infection, organ damage
from “crises”, and both strokes and heart attacks. Most patients experience an
average of one “crisis” each year. These attacks often result in hospitalization.
Some patients have several episodes of severe illness each year. Each episode
can cause organ and nerve damage that may persist after the attack.
Episodes can be mild or
severe. In more severe attacks, life-threatening problems can occur, such as a
stroke or breathing problems due to fluid in the lungs. Potential complications
include:
- Anemia caused by splenic
breakdown of sickle cell RBC’s.
- Blood clots (thrombosis)
- Pain in various parts of
the body, especially the joints
- Stroke
- Eye problems (proliferative
retinopathy)
- Infections, such as
pneumonia
- Fluid in the lungs
during severe attacks
- Enlarged heart or heart
murmur
- Liver problems, such as
jaundice and gallstones
- Blockage of the
spleen/loss of spleen function
- Kidney damage
- Painful erections
(priapism)
- Bone problems
(osteomyelitis and avascular necrosis)
- Leg ulcers
- Delayed growth
In 1995 the FDA began
evaluating the use of the drug hydroxyurea for the treatment of Sickle Cell
Disease. Hydroxyurea can reduce the number of attacks a patient might otherwise
experience but is not appropriate for children and can be toxic. Depending upon
the degree or severity of the disease, young Sickle Cell patients may undergo
antibiotic prophylaxis.
The primary treatment of
Sickle Cell “crises” is rehydration and pain control. Pain can be of
excruciating severity and may require both non-steroidal anti-inflammatory
agents and major narcotics of the opiate class.
Cannabis does not cure
Sickle Cell but is a highly effective agent in managing pain. Patients
utilizing medical cannabis can expect better pain relief with lower doses of
major narcotics. Cannabis also acts as a powerful anti-inflammatory without
NSAID side effects. Cannabis acts both centrally in the brain and directly in
the periphery. Further, cannabis provides neuroprotective effects that may
reduce the incidence of retinopathy and neuropathy.
Some resources for more
information about Sickle Cell Disease can be found at:
Harvard
Medical School on Sickle Cell Disease
FDA Facts
National Institute on
Health Blood Disorders
National
Institute on Health- Treatment for Sickle Cell
WebMD-Medscape
on Sickle Cell Disease
Top |
Home |
Mission |
Patient Resources |
Medical Uses |
News & Events |
Recipes
Search |
Message Board |
Gallery |
Contribute |
Links |
Contact Us
|